Metabolome and inflammasome in inflammatory bowel disease

Translational Research

Volumn 160, Issue 1, 2012, Pages 1-28

  Nanau, Radu M ^a   Neuman, Manuela G ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; C REACTIVE PROTEIN; CALGRANULIN; CD14 ANTIGEN; CHITOBIOSIDE ANTIBODY; CLAUDIN 3; CXCL16 CHEMOKINE; GALECTIN 3; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INFLAMMASOME; LACTOFERRIN; MANNAN ANTIBODY; PROTEIN S 100; RANTES; RETINOL BINDING PROTEIN 4; SUPPRESSOR OF CYTOKINE SIGNALING 2; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR I; TUMOR NECROSIS FACTOR ALPHA RECEPTOR II; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; CELL ADHESION; CELL GROWTH; CROHN DISEASE; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE COURSE; ENDOPLASMIC RETICULUM STRESS; ENTERITIS; ERYTHROCYTE SEDIMENTATION RATE; FECES LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; METABOLOME; NONHUMAN; PHAGOSOME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN URINE LEVEL; REMISSION; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; TH1 CELL; ULCERATIVE COLITIS;

EID: 84862009661     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2011.08.006     Document Type: Review

References (65)

1. M.G. Neuman Immune dysfunction in inflammatory bowel disease Transl Res 149 2007 173 186
2. M.G. Neuman Signaling for inflammation and repair in inflammatory bowel disease Rom J Gastroenterol 13 2004 309 316
3. L.R. Ferguson, I. Peterman, C. Hübner, M. Philpott, and A.N. Shellin Uncoupling gene-diet interactions in inflammatory bowel disease (IBD) Genes Nutr 2 2007 71 73
4. C. Reiff, and D. Kelly Inflammatory bowel disease, gut bacteria and probiotic therapy Int J Med Microbiol 300 2010 25 33
5. F. Carbonnel, P. Jantchou, E. Monnet, and J. Cosnes Environmental risk factors in Crohn's disease and ulcerative colitis: an update Gastroenterol Clin Biol 33 2009 S145 S157
6. C.N. Bernstein New insights into IBD epidemiology: are there any lessons for treatment? Dig Dis 28 2010 406 410
7. M.D. Kappelman, S.L. Rifas-Shiman, and K. Kleinman The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States Clin Gastroenterol Hepatol 5 2007 1424 1429
8. K. Karolewska-Bochenek, I. Lazowska-Przeorek, and P. Albrecht Epidemiology of inflammatory bowel disease among children in Poland. A prospective, population-based, 2-year study, 2002-2004 Digestion 79 2009 121 129
9. L.M. Ward, F. Rauch, and M.A. Matzinger Iliac bone histomorphometry in children with newly diagnosed inflammatory bowel disease Osteoporos Int 21 2010 331 337
10. F.M. Ruemmele, M.G. El Khoury, and C. Talbotec Characteristics of inflammatory bowel disease with onset during the first year of life J Pediatr Gastroenterol Nutr 43 2006 603 609
11. D.Y. Han, A.G. Fraser, P. Dryland, and L.R. Ferguson Environmental factors in the development of chronic inflammation: a case-control study on risk factors for Crohn's disease within New Zealand Mutat Res 690 2010 116 122
12. T. Nagaishi, Z. Chen, and L. Chen CEACAM1 and the regulation of mucosal inflammation Mucosal Immunol 1 2008 S39 S42
13. B. Siegmund Targeted therapies in inflammatory bowel disease Dig Dis 27 2009 465 469
14. I. Dotan, S. Fishman, and Y. Dgani Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease Gastroenterology 131 2006 366 378
15. S. Desplat-Jégo, C. Johanet, and A. Escande Update on Anti-Saccharomyces cerevisiae antibodies, antinuclear associated antineutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: results of a multicenter study World J Gastroenterol 13 2007 2312 2318
16. E. Mainardi, V. Villanacci, and G. Bassotti Diagnostic value of serological assays in pediatric inflammatory bowel disorders Digestion 75 2007 210 214
17. M. Papp, I. Altorjay, and G.L. Norman Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients Inflamm Bowel Dis 13 2007 984 992
18. R.K. Russell, B. Ip, and M.C. Aldhous Anti-Saccharomyces cerevisiae antibodies status is associated with oral involvement and disease severity in Crohn disease J Pediatr Gastroenterol Nutr 48 2009 161 167
19. I.C. Solberg, I. Lygren, and M. Cvancarova Predictive value of serologic markers in a population-based Norwegian cohort with inflammatory bowel disease Inflamm Bowel Dis 15 2009 406 414
20. K. Malickova, P.L. Lakatos, and M. Bortlik Anticarbohydrate antibodies as markers of inflammatory bowel disease in a Central European cohort Eur J Gastroenterol Hepatol 22 2010 144 150
21. F. Rieder, S. Schleder, and A. Wolf Association of the novel serologic anti-glycan antibodies anti-laminarin and anti-chitin with complicated Crohn's disease behavior Inflamm Bowel Dis 16 2010 263 274
22. C.H. Seow, J.M. Stempak, and W. Xu Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype Am J Gastroenterol 104 2009 1426 1434
23. E. Homšak, D. Mičetid-Turk, and B. Božič Autoantibodies pANCA, GAB and PAB in inflammatory bowel disease: prevalence, characteristics and diagnostic value Wien Klin Wochenschr 122 2010 19 25
24. T.D. Jaskowski, C.M. Litwin, and H.R. Hill Analysis of serum antibodies in patients suspected of having inflammatory bowel disease Clin Vaccine Immunol 13 2006 655 660
25. U.L. Fagerberg, L. Lööf, J. Lindholm, L.O. Hansson, and Y. Finkel Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease J Pediatr Gastroenterol Nutr 45 2007 414 420
26. T. Kaiser, J. Langhorst, and H. Wittkowski Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome Gut 56 2007 1706 1713
27. M.A. Sidler, S.T. Leach, and A.S. Day Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children Inflamm Bowel Dis 14 2008 359 366
28. D. Walkiewicz, S.L. Werlin, and D. Fish Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease Inflamm Bowel Dis 14 2008 669 673
29. A. Diamanti, F. Colistro, and M.S. Basso Clinical role of calprotectin assay in determining histological relapses in children affected by inflammatory bowel diseases Inflamm Bowel Dis 14 2008 1229 1235
30. N.S. de Jong, S.T. Leach, and A.S. Day Fecal S100A12: a novel noninvasive marker in children with Crohn's disease Inflamm Bowel Dis 12 2006 566 572
31. S.T. Leach, Z. Yang, and I. Messina Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease Scand J Gastroenterol 42 2007 1321 1331
32. A.C. Manolakis, A.N. Kapsoritakis, and P. Georgoulias Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome BMC Gastroenterol 10 2010 118
33. D. Foell, H. Wittkowski, and Z. Ren Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease J Pathol 216 2008 183 192
34. M.D. Pfefferkorn, J.H. Boone, and J.T. Nguyen Utility of fecal lactoferrin in identifying Crohn disease activity in children J Pediatr Gastroenterol Nutr 51 2010 425 428
35. J. Dai, W.Z. Liu, Y.P. Zhao, Y.B. Hu, and Z.Z. Ge Relationship between fecal lactoferrin and inflammatory bowel disease Scand J Gastroenterol 42 2007 1440 1444
36. R. Sidhu, P. Wilson, and A. Wright Faecal lactoferrin-a novel test to differentiate between the irritable and inflamed bowel? Aliment Pharmacol Ther 31 2010 1365 1370
37. A.M. Schoepfer, M. Trummler, P. Seeholzer, D.H. Criblez, and F. Seibold Accuracy of four fecal assays in the diagnosis of colitis Dis Colon Rectum 50 2007 1697 1706
38. T. Spoettl, M. Hausmann, and F. Klebl Serum soluble TNF receptor I and II levels correlate with disease activity in IBD patients Inflamm Bowel Dis 13 2007 727 732
39. S.L. Haas, M. Abbatista, J. Brade, M.V. Singer, and U. Böcker Interleukin-18 serum levels in inflammatory bowel diseases: correlation with disease activity and inflammatory markers Swiss Med Wkly 139 2009 140 145
40. S. Kugathasan, L.J. Saubermann, and L. Smith Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease Gut 56 2007 1696 1705
41. L. Frolová, K. Smetana Jr., and D. Borovská Detection of galectin-3 in patients with inflammatory bowel diseases: new serum marker of active forms of IBD? Inflamm Res 58 2009 503 512
42. W. Tillinger, R. Jilch, and B. Jilma Expression of the high-affinity IgG receptor FcRI (CD64) in patients with inflammatory bowel disease: a new biomarker for gastroenterologic diagnostics Am J Gastroenterol 104 2009 102 109
43. M. Lehrke, A. Konrad, and V. Schachinger CXCL16 is a surrogate marker of inflammatory bowel disease Scand J Gastroenterol 43 2008 283 288
44. N. Ansari, J. Abdulla, and N. Zayyani Comparison of RANTES expression in Crohn's disease and ulcerative colitis: an aid in the differential diagnosis? J Clin Pathol 59 2006 1066 1072
45. K. Mitsuyama, O. Tsuruta, and N. Tomiyasu Increased circulating concentrations of growth-related oncogene (GRO)-alpha in patients with inflammatory bowel disease Dig Dis Sci 51 2006 173 177
46. L. Valentini, E.K. Wirth, and U. Schweizer Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease Nutrition 25 2009 172 181
47. G. Thuijls, J.P. Derikx, and J.J. de Haan Urine-based detection of intestinal tight junction loss J Clin Gastroenterol 44 2010 e14 e19
48. X. Han, K. Uchida, and I. Jurickova Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn's disease Gastroenterology 136 2009 1261 1271
49. A.J. León, E. Gómez, and J.A. Garrote High levels of proinflammatory cytokines, but not markers of tissue injury, in unaffected intestinal areas from patients with IBD Mediators Inflamm 2009 2009 580450
50. A. Farhadi, A. Keshavarzian, and J.Z. Fields Reduced immunostaining for c-kit receptors in mucosal mast cells in inflammatory bowel disease J Gastroenterol Hepatol 22 2007 2338 2343
51. A. Shkoda, T. Werner, and H. Daniel Differential protein expression profile in the intestinal epithelium from patients with inflammatory bowel disease J Proteome Res 6 2007 1114 1125
52. M. Pierdomenico, L. Stronati, and M. Costanzo New insights into the pathogenesis of inflammatory bowel disease: transcription factors analysis in bioptic tissues from pediatric patients J Pediatr Gastroenterol Nutr 52 2011 271 279
53. M.R. Amin, T. Orenuga, and S. Tyagi Tumor necrosis factor-α represses the expression of NHE2 through NF-κB activation in intestinal epithelial cell model, C2BBe1 Inflamm Bowel Dis 17 2011 720 731
54. F.P. Martin, S. Rezzi, and D. Philippe Metabolic assessment of gradual development of moderate experimental colitis in IL-10 deficient mice J Proteome Res 8 2009 2376 2387
55. A. Messlik, S. Schmechel, and S. Kisling Loss of Toll-like receptor 2 and 4 leads to differential induction of endoplasmic reticulum stress and proapoptotic responses in the intestinal epithelium under conditions of chronic inflammation J Proteome Res 8 2009 4406 4417
56. T.B. Murdoch, H. Fu, and S. MacFarlane Urinary metabolic profiles of inflammatory bowel disease in interleukin-10 gene-deficient mice Anal Chem 80 2008 5524 5531
57. A. Shkoda, P.A. Ruiz, and H. Daniel Interleukin-10 blocked endoplasmic reticulum stress in intestinal epithelial cells: impact on chronic inflammation Gastroenterology 132 2007 190 207
58. E.R. Eckhardt, J. Witta, and J. Zhong Intestinal epithelial serum amyloid A modulates bacterial growth in vitro and pro-inflammatory responses in mouse experimental colitis BMC Gastroenterol 10 2010 133
59. L. Ferrier, C. Serradeil-Le Gal, and A.M. Schulte Proinflammatory role of vasopressin through V1b receptors in hapten-induced experimental colitis in rodents: implication in IBD Am J Physiol Gastrointest Liver Physiol 299 2010 G1298 G1307
60. B.R. Yacyshyn Adhesion molecule therapeutics in IBD Inflamm Bowel Dis 14 2008 S279 S280
61. I. Arijs, G. De Hertogh, and K. Machiels Mucosal gene expression of cell adhesion molecules, chemokines, and chemokine receptors in patients with inflammatory bowel disease before and after infliximab treatment Am J Gastroenterol 106 2011 748 761
62. D.G. Binion, J. Heidemann, and M.S. Li Vascular cell adhesion molecule-1 expression in human intestinal microvascular endothelial cells is regulated by PI 3 kinase/Akt/MAPK/ NFkappaB: inhibitory role of curcumin Am J Physiol Gastrointest Liver Physiol 297 2009 G259 G268
63. T. Mizushima, M. Sasaki, and T. Ando Blockage of angiotensin II type 1 receptor regulates TNF-alpha- induced MAdCAM-1 expression via inhibition of NF-kappaB translocation to the nucleus and ameliorates colitis Am J Physiol Gastrointest Liver Physiol 298 2010 G255 G266
64. T. Stefanelli, A. Malesci, S.A. De La Rue, and S. Danese Anti-adhesion molecule therapies in inflammatory bowel disease: touch and go Autoimmun Rev 7 2008 364 369
65. J.D. Schulzke, S. Ploeger, and M. Amasheh Epithelial tight junctions in intestinal inflammation Ann N Y Acad Sci 1165 2009 294 300